Henter pris…
Værdiansættelse (TTM)
Kursudvikling
Data-readiness
10 års prishistorik er idealet for høj confidence.
- Prishistorik
- 30,1 år
- Pris-dage
- 7584
- Årsregnskaber
- 19
- Peers
- 0/0
- Valuation
- 5/6
- Fundamentals
- 8/8
- Datovindue
- 1996-04-30 til 2026-06-22
Blokkere
- Raw confidence is below the 0.95 high-confidence guardrail.
Mangler før højere confidence
- Kør compute-multiples for manglende valuation metrics.
Seneste assessment
GILD vurderet 2026-06-23
Raw confidence is below the 0.95 high-confidence guardrail.
Stores exit-aware fields without issuing sell scores yet.
Current drawdown: Future exit logic can use drawdown from recent high.
Trend break: Future exit logic can use moving-average trend breaks.
Compares price paid with earnings, cash-generation proxies and sales.
P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.
Earnings yield: Earnings yield is the inverse P/E lens.
Checks trend, momentum and current damage from recent highs.
6M momentum: Positive medium-term momentum confirms sponsorship.
Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.
Checks whether the assessment has enough recent price, fundamental and valuation data.
Price history depth: More than one trading year gives the technical pillar enough context.
Latest price freshness: Latest live or EOD price should be recent.
Treats macro as context, not a standalone trading instruction.
VIX: Normal volatility is supportive; panic or complacency is less clean.
10Y-2Y curve: Positive yield curve lowers recession stress.
Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.
Revenue growth 3Y: Sustained top-line growth supports durable compounding.
Gross margin: High gross margin gives room for reinvestment and downturns.
Adds relative context when sector peers have comparable data.
Peer count: Peer context is only scored when comparable data exists.
P/E vs peers: Own P/E 18.3 vs peer median 16.2; broadly in line with the peer set.
Insider activity
| Dato | Person | Rolle | Type | Antal | Værdi | Kilde |
|---|---|---|---|---|---|---|
| 15.6.2026 | Dickinson Andrew D | Chief Financial Officer | ▼ SALG | -3.000 | -376.200 USD | sec |
| 15.6.2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | ▼ SALG | -1.480 | -182.657 USD | sec |
| 10.6.2026 | O'Day Daniel Patrick | Chairman & CEO | · ANDET | -4.213 | -511.795 USD | sec |
| 10.6.2026 | Berger Dietmar | Chief Medical Officer | · ANDET | -263 | -31.949 USD | sec |
| 10.6.2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | ◆ OPT. | 2.796 | — | sec |
| 10.6.2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | · ANDET | -1.341 | -162.905 USD | sec |
| 10.6.2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | ◆ OPT. | 589 | — | sec |
| 10.6.2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | · ANDET | -283 | -34.379 USD | sec |
| 10.6.2026 | Dickinson Andrew D | Chief Financial Officer | ◆ OPT. | 2.796 | — | sec |
| 10.6.2026 | Dickinson Andrew D | Chief Financial Officer | · ANDET | -1.341 | -162.905 USD | sec |
| 10.6.2026 | O'Day Daniel Patrick | Chairman & CEO | ◆ OPT. | 8.779 | — | sec |
| 10.6.2026 | Berger Dietmar | Chief Medical Officer | ◆ OPT. | 533 | — | sec |
| 1.6.2026 | O'Day Daniel Patrick | Chairman & CEO | ▼ SALG | -10.900 | -1.428.983 USD | sec |
| 26.5.2026 | GILEAD SCIENCES, INC. | — | · ANDET | 471.698 | 12.499.997 USD | sec |
| 15.5.2026 | Dickinson Andrew D | Chief Financial Officer | ▼ SALG | -3.000 | -396.810 USD | sec |
| 15.5.2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | ▼ SALG | -7.749 | -1.009.629 USD | sec |
| 15.5.2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | ◆ OPT. | 25.000 | 1.666.000 USD | sec |
Earnings
| Quarter | Date | EPS actual | EPS est | EPS surprise | Revenue surprise | |
|---|---|---|---|---|---|---|
| 2026Q1 | 30.4.2026 | 2,03 | 1,91 | +6.2% | +6.2% | Beat |
| 2025Q4 | 30.1.2026 | 1,86 | 1,81 | +2.8% | +2.8% | Inline |
| 2025Q3 | 30.10.2025 | 2,47 | 2,14 | +15.7% | +15.7% | Beat |
| 2025Q2 | 30.7.2025 | 2,01 | 1,96 | +2.7% | +2.7% | Inline |